$AGN Company News Actavis expects profit to beat

New Post Public Reply Private Reply Replies (0) Message Board

Feb 3, 2015 at 9:39 AM

$AGN Company News

Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Linn Energy jumps as Tesla, Apple fall 2:30 p.m. Jan. 2, 2015 - Wallace Witkowski
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore

What to Expect When Allergan (AGN) Reports Fourth-Quarter Earnings Tomorrow 3:38 p.m. Feb. 2, 2015 - TheStreet.com
Will Allergan (AGN) Disappoint on Earnings This Quarter? - Analyst Blog 3:20 p.m. Feb. 2, 2015 - Zacks.com
Revenge of the Giants in Stock Picks 5:03 a.m. Jan. 31, 2015 - Barrons.com
Judge Clears Way for Dendreon to Auction Provenge 2:32 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Valeant in Deal to Buy Provenge From Dendreon 10:39 p.m. Jan. 29, 2015 - The Wall Street Journal Interactive Edition
Sientra: A Breast Implant Pure-Play With A Technologically Superior Implant, Initiating Bullish 3:43 p.m. Jan. 29, 2015 - Seeking Alpha
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog 11:23 a.m. Jan. 29, 2015 - Zacks.com
Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog 8:27 a.m. Jan. 29, 2015 - Zacks.com
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog 6:00 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
A Radical Idea for Activist Investors 9:51 a.m. Jan. 27, 2015 - The Wall Street Journal Interactive Edition
Actavis to Buy Auden Mckenzie 8:15 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
A Look At Actavis 2:31 p.m. Jan. 22, 2015 - Seeking Alpha
Trade-Ideas: Allergan (AGN) Is Today's New Lifetime High Stock 9:45 a.m. Jan. 22, 2015 - TheStreet.com
Jim Cramer Sees Actavis Shares Going Higher, Possibly to $320 11:40 a.m. Jan. 21, 2015 - TheStreet.com
The One Fund You Should Own in Your 401k 6:35 a.m. Jan. 21, 2015 - InvestorPlace.com
Salix Pharma Reportedly Exploring Sale; Stock Up 2:06 p.m. Jan. 20, 2015 - Investors Business Daily
Ackman Brings Veteran M&A Lawyer on Board 12:05 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
New Activist Hedge Fund Has CEO Backing 12:00 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog 6:10 p.m. Jan. 19, 2015 - Zacks.com

Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 7:01 p.m. Jan. 30, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
UPDATE - AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:22 p.m. Jan. 20, 2015 - GlobeNewswire
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
ALERT: Rosen Law Firm Reminds Investors Who Sold Allergan Inc. Stock of the Important Class Action Deadline -- AGN 11:11 a.m. Jan. 6, 2015 - GlobeNewswire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 10:32 a.m. Dec. 29, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 Are Encouraged to Contact Glancy Binkow & Goldberg LLP 12:32 p.m. Dec. 23, 2014 - BusinessWire - BZX
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:48 p.m. Dec. 18, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN 3:59 p.m. Dec. 18, 2014 - GlobeNewswire
COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 1:47 p.m. Dec. 17, 2014 - BusinessWire - BZX
Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation 11:15 a.m. Dec. 17, 2014 - GlobeNewswire
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 9:30 a.m. Dec. 17, 2014 - PR Newswire - PRF
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan 9:05 a.m. Dec. 17, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Wilshire Confirms First-to-File Patent Challenge Relating to LASTACAFT® 3:18 p.m. Dec. 11, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Alex Jones Returns to Austin: New Studio, New Plans

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Stravito's MCP Server Revolutionizes AI in Business

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Amy Wilson Joins ITSA Board: A New Era for UBI?

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Sequel Advisors Rebrand: Founder-Centric M&A Focus

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

BeyondCPG Accelerator Launches Seventh Growth Program

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Clarius Named in TIME's Top HealthTech 2026 Again

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

PostalAnnex Lands at Stanford with New Service Hub

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Starr Conspiracy Unveils AI Tool for B2B Tech Firms

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...